Evidence map›Paper›PMID 41612976›Full record

ArticleJournal of cell science2026

A high-yield protein expression platform in the unicellular red alga Cyanidioschyzon merolae.

Yuko Mogi, Shogo Tsushima, Shotaro Nagai, Shinichi Gima, Fumi Yagisawa, Yamato Yoshida

Abstract read
In one paragraph

Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuko MogiDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.ORCID 0009-0002-4584-3047
Shogo TsushimaDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.
Shotaro NagaiDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.
Shinichi GimaIntegrated Technology Center, University of the Ryukyus, Okinawa 903-0213, Japan.
Fumi YagisawaResearch Facility Center, University of the Ryukyus, Okinawa 903-0213, Japan.ORCID 0000-0002-8534-3824
Yamato YoshidaDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.ORCID 0000-0002-2339-2938

Funding

Fusion Oriented REsearch for disruptive Science and Technology JPMJFR2316Japan Science and Technology Agency JPMJFR2316Japan Society for the Promotion of Science 22H02653Japan Society for the Promotion of Science 25K09727Japan Society for the Promotion of Science JP18K06325University of Tokyo
6 · The paper itself

Abstract

The production of engineered proteins in transgenic cells is widely used in research, medicine and industry. However, conventional cell-based production systems still face challenges in cost, scalability and biosafety. Here, we present a recombinant protein expression platform with simplified purification based on the photosynthetic unicellular red alga Cyanidioschyzon merolae, which can be cultivated under highly acidic conditions using only inorganic nutrients, air, water and light. We first identified a promoter that drives high-level constitutive gene expression throughout the cell cycle, resulting in substantial mRNA accumulation in C. merolae. A stable transformant expressing His-tagged mVenus under the control of this promoter accumulated the recombinant protein to more than 1% of total soluble protein. The simple cellular architecture of C. merolae, including the absence of a cell wall, enables efficient protein extraction via a single freeze-thaw cycle, followed by purification using immobilized metal affinity chromatography (IMAC), yielding ∼13.9 mg of functional recombinant protein per gram of total soluble protein. Owing to its low cost, scalability, operational simplicity and minimal risk of contamination, this Cyanidioschyzon-based platform offers a practical and promising approach to recombinant protein production in a photosynthetic eukaryote.

Indexed as

Recombinant ProteinsRhodophytaPromoter Regions, GeneticRecombinant ProteinsAlgaCyanidioschyzon merolaeRecombinant protein purification

Identifiers

PMID41612976
PMCPMC12989068

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.